A combination of the immunohistochemical markers CK7 and SATB2 is highly sensitive and specific for distinguishing primary ovarian mucinous tumors from colorectal and appendiceal metastases
Nicola S. Meagher(The University of Sydney), Raghwa Sharma(Royal Prince Alfred Hospital), Oleg Oszurek(International Hereditary Cancer Center), Neil Lambie(New South Wales Department of Health), Kunle Odunsi(University of Chicago), Ellen L. Goode(Mayo Clinic in Arizona), Helen Steed(University of Alberta), Rhonda Farrell(Prince of Wales Hospital), Lynne R. Wilkens(University of Hawaiʻi at Mānoa), Michael E. Carney(The University of Texas MD Anderson Cancer Center), Robert A. Vierkant(Mayo Clinic), Linda E. Kelemen(Medical University of South Carolina), Jan Lubiński(Tumour Institute of Tuscany), Stacey J. Winham(Mayo Clinic), Michael S. Anglesio(University of British Columbia), Brenda Y. Hernandez(Cancer Center of Hawaii), Anthony J. Swerdlow(Institute of Cancer Research), Marc T. Goodman(Cedars-Sinai Medical Center), Bonnie Zhang(St John of God Subiaco Hospital), Peter Rambau(Catholic University of Health and Allied Sciences), Yanina Natanzon, Catherine J. Kennedy(The University of Sydney), Sabine Behrens(German Cancer Research Center), Christine Chow(Whitehead Institute for Biomedical Research), Kirsten B. Moysich(American Cancer Society), Adeline Tan(Albert Einstein College of Medicine), Karin Sundfeldt(Sahlgrenska University Hospital), Maria P. Intermaggio(The University of Melbourne), Gregory Robertson(UNSW Sydney), John Lewis Etter(Roswell Park Comprehensive Cancer Center), Robert P. Edwards(Cancer Research UK Technology), Mona El‐Bahrawy(Al-Azhar University), Francesmary Modugno(University of Pittsburgh), Montserrat García‐Closas(Institute of Cancer Research), Yee Leung(King Edward Memorial Hospital), Esther Herpel(Memorial Sloan Kettering Cancer Center), Aline Talhouk(University of British Columbia), Usha Menon(University of South Florida), Paul Klonowski(University of Calgary), Tomasz Kluz(University of Rzeszów), David G. Huntsman(BC Cancer Agency), Sanela Bilic, Jacek Gronwald(International Hereditary Cancer Center), Qin Wang(University of Cambridge), Linyuan Wang(Beijing University of Chinese Medicine), Gary L. Keeney(Mayo Clinic in Arizona), Roberta B. Ness(The University of Texas Health Science Center at Houston), Mercedes Jimenez‐Liñan(University of Kansas), Aleksandra Tołoczko‐Grabarek(Pomeranian Medical University), Janusz Menkiszak(Pomeranian Medical University)
Cited by 104
Related Papers
Integrated genomic analyses of ovarian carcinoma
|Nature|2011|8.2k
Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
|New England Journal of Medicine|2012|8k
Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies
|The American Journal of Human Genetics|2003|3.7k
Intraepithelial CD8 <sup>+</sup> tumor-infiltrating lymphocytes and a high CD8 <sup>+</sup> /regulatory T cell ratio are associated with favorable prognosis in ovarian cancer
|Proceedings of the National Academy of Sciences|2005|2.4k